Procter & Gamble (NYSE: PG) officer to sell 6,569 shares

Rhea-AI Filing Summary

PROCTER & GAMBLE Co (PG) received a Rule 144 notice indicating that company officer Andre Schulten plans a sale of Procter & Gamble common stock. The notice covers a proposed sale of 6,569 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of approximately $947,019.89 based on the average of the high and low trading prices on August 14, 2026. The planned sale date listed is August 19, 2026 on the NYSE, and the shares relate to a Performance Stock Program Award.

Key Figures

Shares to be sold: 6,569 shares Aggregate market value: $947,019.89 Planned sale date: 08/19/2026 +1 more

4 metrics

Shares to be sold 6,569 shares Common stock proposed to be sold under Rule 144

Aggregate market value $947,019.89 Value of 6,569 shares based on average of high and low on August 14, 2026

Planned sale date 08/19/2026 Intended date of sale of common stock on NYSE

Issuer phone number 5139831100 Contact phone for The Procter & Gamble Company

Key Terms

Rule 144, Performance Stock Program Award, attorney-in-fact, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Stock Program Award financial

"Common Stock | 08/19/2026 | Performance Stock Program Award |"

attorney-in-fact regulatory

"Signature | /s/ Wednesday Shipp, attorney-in-fact for Andre Schulten"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

aggregate market value financial

"| 6569 | 947019.89 | 2324433060 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What stock sale is disclosed for PROCTER & GAMBLE Co (PG) in this Rule 144 notice?

The notice discloses a planned sale of 6,569 shares of Procter & Gamble common stock by officer Andre Schulten through Morgan Stanley Smith Barney LLC, in a transaction reported under Rule 144.

What is the approximate value of the PROCTER & GAMBLE Co (PG) shares covered by this filing?

The filing reports an aggregate market value of about $947,019.89 for the 6,569 Procter & Gamble shares, calculated using the average of the high and low stock prices on August 14, 2026.

When is the planned sale date for the PROCTER & GAMBLE Co (PG) shares?

The proposed sale date for the Procter & Gamble common stock under this notice is August 19, 2026, with the shares to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

Who is the selling security holder in this PROCTER & GAMBLE Co (PG) Rule 144 filing?

The planned sale is for the account of Andre Schulten, identified as an officer of Procter & Gamble, with Morgan Stanley Smith Barney LLC Executive Financial Services acting as the broker.

What type of equity award is associated with the PROCTER & GAMBLE Co (PG) shares being sold?

The shares referenced in the planned Rule 144 sale are associated with a Performance Stock Program Award from The Procter & Gamble Company, indicating they originated from an equity compensation program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 10:54 AM Accepted by SEC EDGAR 08/18/2026 - 10:53 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001844763
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCTER & GAMBLE Co
SEC File Number	001-00434
Address of Issuer	ONE PROCTER & GAMBLE PLAZA CINCINNATI OHIO 45202
Phone	5139831100
Name of Person for Whose Account the Securities are To Be Sold	Schulten Andre
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	6569	947019.89	2324433060	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/19/2026	Performance Stock Program Award	The Procter & Gamble Company			19372	08/19/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Based on average of high and low price on August 14, 2026.
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wednesday Shipp, attorney-in-fact for Andre Schulten
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)